102 related articles for article (PubMed ID: 8906274)
1. The kynurenines and the seizures.
Guzeva VI; Mikhailov IB; Melnikova NV
Adv Exp Med Biol; 1996; 398():263-4. PubMed ID: 8906274
[No Abstract] [Full Text] [Related]
2. Effect of tryptophan metabolites on activity of the epileptogenic focus in the frog hippocampus.
Gusel WA; Mikhailov IB
J Neural Transm; 1980; 47(1):41-52. PubMed ID: 6766985
[TBL] [Abstract][Full Text] [Related]
3. Regulation of quinolinic acid in the normal rat brain by kynurenine pathway precursors.
Luthman J; Vänerman E; Fredriksson G; Fornstedt-Wallin B
Adv Exp Med Biol; 1996; 398():229-39. PubMed ID: 8906270
[No Abstract] [Full Text] [Related]
4. Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice.
Lapin IP
J Neural Transm; 1978; 42(1):37-43. PubMed ID: 641543
[TBL] [Abstract][Full Text] [Related]
5. Kynurenic acid antagonizes hippocampal quinolinic acid neurotoxicity: behavioral and histological evaluation.
Lekieffre D; Plotkine M; Allix M; Boulu RG
Neurosci Lett; 1990 Nov; 120(1):31-3. PubMed ID: 2149878
[TBL] [Abstract][Full Text] [Related]
6. Kynurenines do not antagonise GABA in rat hippocampus.
Stone TW
Eur J Pharmacol; 1986 Aug; 128(1-2):81-3. PubMed ID: 3758189
[TBL] [Abstract][Full Text] [Related]
7. [Electroencephalographic manifestations of the convulsive reaction of rats to the intraventricular administration of quinolinic acid and kynurenine].
Kozlovskiĭ VB; Prakh'e IV
Farmakol Toksikol; 1988; 51(6):26-9. PubMed ID: 2976682
[TBL] [Abstract][Full Text] [Related]
8. [Effect of kynurenines on the actions of acetylcholine, oxotremorine, and nicotine].
Bel'gova IN; Lapin IP; Nezhentsev MV; Umanskaia LG
Farmakol Toksikol; 1981; 44(2):163-6. PubMed ID: 6456153
[TBL] [Abstract][Full Text] [Related]
9. Kynurenic acid influences the respiratory parameters of rat heart mitochondria.
Baran H; Staniek K; Kepplinger B; Gille L; Stolze K; Nohl H
Pharmacology; 2001 Feb; 62(2):119-23. PubMed ID: 11174083
[TBL] [Abstract][Full Text] [Related]
10. Kynurenines impair energy metabolism in rat cerebral cortex.
Schuck PF; Tonin A; da Costa Ferreira G; Viegas CM; Latini A; Duval Wannmacher CM; de Souza Wyse AT; Dutra-Filho CS; Wajner M
Cell Mol Neurobiol; 2007 Feb; 27(1):147-60. PubMed ID: 17151944
[TBL] [Abstract][Full Text] [Related]
11. The analgesic effects of tryptophan and its metabolites in the rat.
Heyliger SO; Goodman CB; Ngong JM; Soliman KF
Pharmacol Res; 1998 Oct; 38(4):243-50. PubMed ID: 9774487
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of kynurenine-induced seizures by picolinic, kynurenic and xanthurenic acids.
Lapin IP
J Neural Transm; 1983; 56(2-3):177-85. PubMed ID: 6864208
[TBL] [Abstract][Full Text] [Related]
13. An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.
Perkins MN; Stone TW
Brain Res; 1982 Sep; 247(1):184-7. PubMed ID: 6215086
[No Abstract] [Full Text] [Related]
14. [Effects of antagonists of exciting amino acids on the neuro-destructive effect of quinolinic acid in vitro in comparison with their anticonvulsive action in situ].
Khaspekov LG; Lapin IP; Ryzhov IV; Viktorov IV
Biull Eksp Biol Med; 1989 Aug; 108(8):190-3. PubMed ID: 2529920
[TBL] [Abstract][Full Text] [Related]
15. Basic mechanisms of kynurenine actions in the central nervous system.
Stone TW; MacGregor DG; Smith RA; Jones P; Behan WM; Graham DI
Adv Exp Med Biol; 1996; 398():195-201. PubMed ID: 8906266
[No Abstract] [Full Text] [Related]
16. Anti-excitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro.
French ED; Vezzani A; Whetsell WO; Schwarcz R
Adv Exp Med Biol; 1986; 203():349-62. PubMed ID: 2947421
[No Abstract] [Full Text] [Related]
17. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
18. [Stimulatory effects of intraventricular administration of kynurenines, amino acids, and convulsants: differences between rats and mice].
Prakh'e IB; Kiseleva IP; Lapin IP
Fiziol Zh SSSR Im I M Sechenova; 1982 Nov; 68(11):1516-21. PubMed ID: 7152052
[TBL] [Abstract][Full Text] [Related]
19. [Changes in the activity of an epileptogenic focus in the hippocampus of rats treated with the chief metabolites of tryptophan].
Mikhaĭlov IB
Farmakol Toksikol; 1981; 44(2):143-6. PubMed ID: 6944206
[TBL] [Abstract][Full Text] [Related]
20. Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2
Forrest CM; Kennedy PG; Rodgers J; Dalton RN; Turner C; Darlington LG; Cobb SR; Stone TW
Neurochem Int; 2016 Nov; 100():110-119. PubMed ID: 27623092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
